The global Dysphagia Lusoria Treatment market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Dysphagia lusoria is a medical condition characterized by difficulty swallowing (dysphagia) due to the presence of an aberrant or anomalous right subclavian artery that compresses the esophagus. The right subclavian artery typically branches off the aorta in a specific location, but in cases of dysphagia lusoria, it takes a different path, causing compression and obstructing the esophagus. Treatment options for dysphagia lusoria aim to alleviate the compression of the esophagus and improve swallowing function.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Dysphagia Lusoria Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Dysphagia Lusoria Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dysphagia Lusoria Treatment. This report contains market size and forecasts of Dysphagia Lusoria Treatment in global, including the following market information:
Global Dysphagia Lusoria Treatment market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Dysphagia Lusoria Treatment companies in 2024 (%)
Total Market by Segment:
Global Dysphagia Lusoria Treatment market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Dysphagia Lusoria Treatment market segment percentages, by Type, 2024 (%)
Operation Treatment
Medical Treatement
Global Dysphagia Lusoria Treatment market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Dysphagia Lusoria Treatment market segment percentages, by Application, 2024 (%)
Hospitals
Clinics
Retail Pharmacy
Others
Global Dysphagia Lusoria Treatment market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Dysphagia Lusoria Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dysphagia Lusoria Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Dysphagia Lusoria Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb Company
Pfizer
AstraZeneca plc
Perrigo Company plc
Johnson & Johnson
Teva Pharmaceuticals
Medtronic plc
Torax Medical
GlaxoSmithKline Plc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dysphagia Lusoria Treatment, market overview.
Chapter 2: Global Dysphagia Lusoria Treatment market size in revenue.
Chapter 3: Detailed analysis of Dysphagia Lusoria Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dysphagia Lusoria Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dysphagia Lusoria Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Dysphagia Lusoria Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dysphagia Lusoria Treatment Overall Market Size
2.1 Global Dysphagia Lusoria Treatment Market Size: 2024 VS 2032
2.2 Global Dysphagia Lusoria Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dysphagia Lusoria Treatment Players in Global Market
3.2 Top Global Dysphagia Lusoria Treatment Companies Ranked by Revenue
3.3 Global Dysphagia Lusoria Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dysphagia Lusoria Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Dysphagia Lusoria Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Dysphagia Lusoria Treatment Players in Global Market
3.6.1 List of Global Tier 1 Dysphagia Lusoria Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Dysphagia Lusoria Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Dysphagia Lusoria Treatment Market Size Markets, 2024 & 2032
4.1.2 Operation Treatment
4.1.3 Medical Treatement
4.2 Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Dysphagia Lusoria Treatment Market Size, 2024 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Retail Pharmacy
5.1.5 Others
5.2 Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Dysphagia Lusoria Treatment Market Size, 2024 & 2032
6.2 By Region - Global Dysphagia Lusoria Treatment Revenue & Forecasts
6.2.1 By Region - Global Dysphagia Lusoria Treatment Revenue, 2020-2025
6.2.2 By Region - Global Dysphagia Lusoria Treatment Revenue, 2026-2032
6.2.3 By Region - Global Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Dysphagia Lusoria Treatment Revenue, 2020-2032
6.3.2 United States Dysphagia Lusoria Treatment Market Size, 2020-2032
6.3.3 Canada Dysphagia Lusoria Treatment Market Size, 2020-2032
6.3.4 Mexico Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Dysphagia Lusoria Treatment Revenue, 2020-2032
6.4.2 Germany Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4.3 France Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4.4 U.K. Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4.5 Italy Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4.6 Russia Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Dysphagia Lusoria Treatment Market Size, 2020-2032
6.4.8 Benelux Dysphagia Lusoria Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Dysphagia Lusoria Treatment Revenue, 2020-2032
6.5.2 China Dysphagia Lusoria Treatment Market Size, 2020-2032
6.5.3 Japan Dysphagia Lusoria Treatment Market Size, 2020-2032
6.5.4 South Korea Dysphagia Lusoria Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Dysphagia Lusoria Treatment Market Size, 2020-2032
6.5.6 India Dysphagia Lusoria Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Dysphagia Lusoria Treatment Revenue, 2020-2032
6.6.2 Brazil Dysphagia Lusoria Treatment Market Size, 2020-2032
6.6.3 Argentina Dysphagia Lusoria Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dysphagia Lusoria Treatment Revenue, 2020-2032
6.7.2 Turkey Dysphagia Lusoria Treatment Market Size, 2020-2032
6.7.3 Israel Dysphagia Lusoria Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Dysphagia Lusoria Treatment Market Size, 2020-2032
6.7.5 UAE Dysphagia Lusoria Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 Bristol-Myers Squibb Company
7.1.1 Bristol-Myers Squibb Company Corporate Summary
7.1.2 Bristol-Myers Squibb Company Business Overview
7.1.3 Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Major Product Offerings
7.1.4 Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.1.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Dysphagia Lusoria Treatment Major Product Offerings
7.2.4 Pfizer Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.2.5 Pfizer Key News & Latest Developments
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Corporate Summary
7.3.2 AstraZeneca plc Business Overview
7.3.3 AstraZeneca plc Dysphagia Lusoria Treatment Major Product Offerings
7.3.4 AstraZeneca plc Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.3.5 AstraZeneca plc Key News & Latest Developments
7.4 Perrigo Company plc
7.4.1 Perrigo Company plc Corporate Summary
7.4.2 Perrigo Company plc Business Overview
7.4.3 Perrigo Company plc Dysphagia Lusoria Treatment Major Product Offerings
7.4.4 Perrigo Company plc Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.4.5 Perrigo Company plc Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Dysphagia Lusoria Treatment Major Product Offerings
7.5.4 Johnson & Johnson Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Teva Pharmaceuticals
7.6.1 Teva Pharmaceuticals Corporate Summary
7.6.2 Teva Pharmaceuticals Business Overview
7.6.3 Teva Pharmaceuticals Dysphagia Lusoria Treatment Major Product Offerings
7.6.4 Teva Pharmaceuticals Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.6.5 Teva Pharmaceuticals Key News & Latest Developments
7.7 Medtronic plc
7.7.1 Medtronic plc Corporate Summary
7.7.2 Medtronic plc Business Overview
7.7.3 Medtronic plc Dysphagia Lusoria Treatment Major Product Offerings
7.7.4 Medtronic plc Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.7.5 Medtronic plc Key News & Latest Developments
7.8 Torax Medical
7.8.1 Torax Medical Corporate Summary
7.8.2 Torax Medical Business Overview
7.8.3 Torax Medical Dysphagia Lusoria Treatment Major Product Offerings
7.8.4 Torax Medical Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.8.5 Torax Medical Key News & Latest Developments
7.9 GlaxoSmithKline Plc.
7.9.1 GlaxoSmithKline Plc. Corporate Summary
7.9.2 GlaxoSmithKline Plc. Business Overview
7.9.3 GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Major Product Offerings
7.9.4 GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Revenue in Global Market (2020-2025)
7.9.5 GlaxoSmithKline Plc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dysphagia Lusoria Treatment Market Opportunities & Trends in Global Market
Table 2. Dysphagia Lusoria Treatment Market Drivers in Global Market
Table 3. Dysphagia Lusoria Treatment Market Restraints in Global Market
Table 4. Key Players of Dysphagia Lusoria Treatment in Global Market
Table 5. Top Dysphagia Lusoria Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Dysphagia Lusoria Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Dysphagia Lusoria Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Dysphagia Lusoria Treatment Product Type
Table 9. List of Global Tier 1 Dysphagia Lusoria Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dysphagia Lusoria Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application– Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region– Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2026-2032
Table 30. Bristol-Myers Squibb Company Corporate Summary
Table 31. Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Product Offerings
Table 32. Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Bristol-Myers Squibb Company Key News & Latest Developments
Table 34. Pfizer Corporate Summary
Table 35. Pfizer Dysphagia Lusoria Treatment Product Offerings
Table 36. Pfizer Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Pfizer Key News & Latest Developments
Table 38. AstraZeneca plc Corporate Summary
Table 39. AstraZeneca plc Dysphagia Lusoria Treatment Product Offerings
Table 40. AstraZeneca plc Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. AstraZeneca plc Key News & Latest Developments
Table 42. Perrigo Company plc Corporate Summary
Table 43. Perrigo Company plc Dysphagia Lusoria Treatment Product Offerings
Table 44. Perrigo Company plc Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. Perrigo Company plc Key News & Latest Developments
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Dysphagia Lusoria Treatment Product Offerings
Table 48. Johnson & Johnson Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Teva Pharmaceuticals Corporate Summary
Table 51. Teva Pharmaceuticals Dysphagia Lusoria Treatment Product Offerings
Table 52. Teva Pharmaceuticals Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. Teva Pharmaceuticals Key News & Latest Developments
Table 54. Medtronic plc Corporate Summary
Table 55. Medtronic plc Dysphagia Lusoria Treatment Product Offerings
Table 56. Medtronic plc Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Medtronic plc Key News & Latest Developments
Table 58. Torax Medical Corporate Summary
Table 59. Torax Medical Dysphagia Lusoria Treatment Product Offerings
Table 60. Torax Medical Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. Torax Medical Key News & Latest Developments
Table 62. GlaxoSmithKline Plc. Corporate Summary
Table 63. GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Product Offerings
Table 64. GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. GlaxoSmithKline Plc. Key News & Latest Developments
List of Figures
Figure 1. Dysphagia Lusoria Treatment Product Picture
Figure 2. Dysphagia Lusoria Treatment Segment by Type in 2024
Figure 3. Dysphagia Lusoria Treatment Segment by Application in 2024
Figure 4. Global Dysphagia Lusoria Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Dysphagia Lusoria Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Dysphagia Lusoria Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Dysphagia Lusoria Treatment Revenue in 2024
Figure 9. Segmentation by Type – Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application – Global Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 15. United States Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 27. China Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Dysphagia Lusoria Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Dysphagia Lusoria Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. Bristol-Myers Squibb Company Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Pfizer Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AstraZeneca plc Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Perrigo Company plc Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Johnson & Johnson Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Teva Pharmaceuticals Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Medtronic plc Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Torax Medical Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. GlaxoSmithKline Plc. Dysphagia Lusoria Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
